The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 417.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 15.00 (3.659%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 417.50
AVG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Aerospace Assets

16 Nov 2012 08:57

16 November Avingtrans plc ("Avingtrans", "Group" or "the Company") Acquisition of Aerospace Assets

Avingtrans plc, which designs, manufactures and supplies critical components and associated services to the global aerospace, energy, and medical sectors, announces that it has agreed to acquire the trade and certain business assets and liabilities relating to the manufacture of aerospace components from PFW UK Limited's Farnborough site ("PFW Farnborough" and the "Acquisition") for a cash consideration of £1.85 million. The acquisition is due to be completed on 3 December 2012, following the completion of final targeted due diligence and employee consultation.

Highlights of the Acquisition:

* Strengthens the Group's Aerospace division * Cash consideration of £1.85m * Reinforces Avingtrans' position with certain existing customers as well as introducing new customers to the Group * Broadens process and design capabilities to expand aerospace market offering

Information on the assets being acquired

The principal activity of the PFW Farnborough business is the manufacture of a wide range of precision aerospace components, from pipes and ducts to airframe structures. The directors of Avingtrans (the "Board") believe that the Acquisition enhances the Group's Aerospace components and sub-assemblies offering and the Board are pleased to have taken further steps in implementing the Group's strategy, outlined recently after the disposal of the Company's Industrial Products division. PFW Farnborough has a number of customers in common with Avingtrans, as well as several customers with whom the Company has no existing commercial relationship. The Board therefore believes that the acquisition will both strengthen its current portfolio and also add valuable new sales channels.

PFW Farnborough generated revenues of £7.5 million* and a trading loss of £1.8 million* during the year ended 31 December 2011. However, the Board believes that its current run rate and the potential is materially higher. The net book value of the assets and liabilities being acquired has been valued at £2.3m million as at 30 September 2012*. PFW Farnborough employs 102 people in the UK, all of whom are expected to transfer to Avingtrans following an appropriate consultation process.

Steve McQuillan, Chief Executive of Avingtrans commented:

"The recent sale of Jena Tec provided us with a more focused business and the means to invest in our core activities, including in our thriving Aerospace division. This acquisition will further strengthen our position in the aerospace pipes market, making us a leading player in this niche in the UK. We will develop the PFW Farnborough capabilities to broaden our product offering and thus expand our aerospace supply footprint.

"With the proceeds from the Jena Tec disposal, we will continue to explore opportunities which would improve our customer reach and thereby further strengthen our position in this attractive market."

* Source: PFW Farnborough unaudited management information, prepared under generally accepted accounting principles in the UK

-ends- Avingtrans plc Tel: 01159 499 020 Steve McQuillan, Chief Executive Officer finnCap (Nominated Advisor & Broker) Tel: 020 7220 0500 Marc Young/ Henrik Persson Newgate Threadneedle(Financial PR) Tel: 020 7653 9850

Josh Royston

XLON
Date   Source Headline
26th Mar 202411:15 amRNSPDMR Dealings
21st Mar 20245:15 pmRNSExercise of Options, PDMR Dealings & TVR
20th Mar 20243:39 pmRNSHolding(s) in Company
4th Mar 20246:10 pmRNSPDMR Dealings
28th Feb 20247:00 amRNSInterim Results
18th Jan 20247:00 amRNSTrading Update and Notice of Results
15th Dec 20233:00 pmRNSExercise of Options & TVR
4th Dec 20237:00 amRNSMagnetica Limited appoints US distributor
22nd Nov 20237:00 amRNSEmployee & PDMR Share Incentive Awards
16th Nov 20232:20 pmRNSResult of AGM
13th Nov 20237:00 amRNSHayward Tyler Contract Win
11th Oct 20237:00 amRNSContract Wins
28th Sep 20235:54 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNSPreliminary results for the year ended 31 May 2023
25th Sep 20237:00 amRNSHolding(s) in Company
18th Sep 20237:00 amRNSCompletion of Acquisition of Adaptix Ltd
4th Sep 20237:00 amRNSBoard Update
7th Aug 20237:00 amRNSAcquisition of Slack & Parr and Adaptix update
13th Jul 20237:00 amRNSTrading Update & Possible Acquisition of Adaptix
5th Jun 20237:00 amRNSBoard Changes
22nd Feb 20237:00 amRNSInterim Results
15th Feb 20237:00 amRNSAdaptix appoints Willem Baralt as new Chairman
30th Jan 20237:00 amRNSAdaptix secures 510(k) clearance from FDA
27th Jan 20231:19 pmRNSEmployee & PDMR Share Incentive Awards
23rd Jan 20236:12 pmRNSPDMR Dealings
18th Jan 20237:00 amRNSAdditional Investment in Magnetica
16th Jan 20237:00 amRNSTrading Update, Acquisitions and Notice of Results
23rd Dec 20228:30 amRNSExercise of Options, PDMR Dealings & TVR
14th Dec 20227:00 amRNSSteve McQuillan appointed as Chairman of Adaptix
17th Nov 20223:56 pmRNSResult of Annual General Meeting
28th Sep 20227:00 amRNSPreliminary results for the year ended 31 May 2022
27th Jul 20222:38 pmRNSHolding(s) in Company
7th Jul 20227:00 amRNSTrading Update and Notice of Results
11th Apr 20227:00 amRNSHayward Tyler Secures Nuclear Contracts worth $7m
6th Apr 202212:59 pmRNSExercise of Options and Total Voting Rights
29th Mar 20225:13 pmRNSPDMR Dealing
21st Mar 20227:00 amRNSEnergy Steel Secures Nuclear Contract worth $4.1m
17th Mar 20227:00 amRNSContract Wins
23rd Feb 20227:00 amRNSDirectorate Change
23rd Feb 20227:00 amRNSInterim Results
20th Jan 20227:00 amRNSTrading Update, Notice of Results and Investment
29th Nov 20215:57 pmRNSEmployee & PDMR Share Incentive Awards
22nd Nov 20212:32 pmRNSExercise of Options, PDMR Dealings and TVR
18th Nov 202112:41 pmRNSResult of AGM
13th Oct 20217:00 amRNSInvestment in emerging medtech leader, Adaptix
29th Sep 20217:00 amRNSPreliminary Results for the year ended 31 May 2021
12th Aug 202112:20 pmRNSExercise of Options and Total Voting Rights
12th Jul 202110:51 amRNSExercise of Options, PDMR Dealings and TVR
12th Jul 20217:00 amRNSAvingtrans’ businesses nuclear contract
8th Jul 20217:00 amRNSTrading Update and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.